BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33012427)

  • 1. Pathology of Malignant Pleural Mesothelioma.
    Hung YP; Chirieac LR
    Thorac Surg Clin; 2020 Nov; 30(4):367-382. PubMed ID: 33012427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
    Chirieac LR; Hung YP; Foo WC; Hofer MD; VanderLaan PA; Richards WG; Sugarbaker DJ; Bueno R
    Cancer; 2019 Dec; 125(23):4164-4171. PubMed ID: 31390057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.
    Dacic S; Le Stang N; Husain A; Weynand B; Beasley MB; Butnor K; Chapel D; Gibbs A; Klebe S; Lantuejoul S; Roden AC; Roggli V; Tazelaar H; Vignaud JM; Galateau-Sallé F
    Mod Pathol; 2020 Feb; 33(2):255-262. PubMed ID: 31273316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural mesothelioma classification update.
    Beasley MB; Galateau-Salle F; Dacic S
    Virchows Arch; 2021 Jan; 478(1):59-72. PubMed ID: 33475835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases.
    Barbieri PG; Consonni D; Schneider M
    Tumori; 2022 Feb; 108(1):26-32. PubMed ID: 33719756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
    Nicholson AG; Sauter JL; Nowak AK; Kindler HL; Gill RR; Remy-Jardin M; Armato SG; Fernandez-Cuesta L; Bueno R; Alcala N; Foll M; Pass H; Attanoos R; Baas P; Beasley MB; Brcic L; Butnor KJ; Chirieac LR; Churg A; Courtiol P; Dacic S; De Perrot M; Frauenfelder T; Gibbs A; Hirsch FR; Hiroshima K; Husain A; Klebe S; Lantuejoul S; Moreira A; Opitz I; Perol M; Roden A; Roggli V; Scherpereel A; Tirode F; Tazelaar H; Travis WD; Tsao MS; van Schil P; Vignaud JM; Weynand B; Lang-Lazdunski L; Cree I; Rusch VW; Girard N; Galateau-Salle F
    J Thorac Oncol; 2020 Jan; 15(1):29-49. PubMed ID: 31546041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1.
    Zaleski M; Kalhor N; Fujimoto J; Wistuba I; Moran CA
    Pathol Res Pract; 2020 Dec; 216(12):153267. PubMed ID: 33176261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy for Malignant Pleural Mesothelioma.
    Rosenzweig KE
    Thorac Surg Clin; 2020 Nov; 30(4):473-480. PubMed ID: 33012434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion surgery for locally advanced malignant pleural mesothelioma.
    Terada Y; Isaka M; Murakami H; Kawata T; Konno H; Kojima H; Mizuno T; Ohde Y
    Gen Thorac Cardiovasc Surg; 2020 Dec; 68(12):1547-1550. PubMed ID: 32166578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma.
    Ripley RT
    Thorac Surg Clin; 2020 Nov; 30(4):451-460. PubMed ID: 33012432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.
    Song KJ; Flores RM; Wolf AS
    Thorac Surg Clin; 2020 Nov; 30(4):481-487. PubMed ID: 33012435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.
    Parra-Medina R; Castañeda-González JP; Chaves-Cabezas V; Alzate JP; Chaves JJ
    Pathol Res Pract; 2024 May; 257():155276. PubMed ID: 38603842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
    Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.
    Wolf AS; Flores RM
    Thorac Surg Clin; 2016 Aug; 26(3):359-75. PubMed ID: 27427530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis.
    Schulte JJ; Chapel DB; Attanoos R; Brcic L; Burn J; Butnor KJ; Chang N; Chen H; Dacic S; De Perrot M; Fukuoka J; Galateau-Salle F; Godschachner T; Hiroshima K; Klebe S; Krausz T; Litzky L; Marchevsky AM; Mueller J; Nabeshima K; Nicholson AG; Pal P; Roden AC; Rorvig S; Santoni-Rugiu E; Tazelaar H; Tsao MS; Walts AE; Weynand B; Zaizen Y; Zhang YZ; Husain AN
    Am J Clin Pathol; 2021 Nov; 156(6):989-999. PubMed ID: 33978147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
    Wolf AS; Daniel J; Sugarbaker DJ
    Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
    McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
    Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapleural pneumonectomies for pleural mesothelioma.
    Faccioli E; Bellini A; Mammana M; Monaci N; Schiavon M; Rea F
    Expert Rev Respir Med; 2020 Jan; 14(1):67-79. PubMed ID: 31674841
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-incisional pleurectomy/decortication for malignant mesothelioma after cardiac surgery.
    Miura K; Shimizu K; Hasegawa S; Koike S; Matsuoka S; Takeda T; Eguchi T; Hamanaka K; Takizawa M
    Thorac Cancer; 2022 Jan; 13(1):126-128. PubMed ID: 34799989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
    Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
    Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.